What do two-year outcomes look like after concomitant epicardial surgical ablation during CABG?
A multicenter analysis of 537 patients from the TRAC-AF Registry found:
- 94% and 89% survival at 12 and 24 months, respectively.
- 85% and 77% freedom from atrial arrhythmias at 12 and 24 months, respectively.
Read more about the findings here: https://okt.to/QKExLU
Robust. Transmural. Contiguous.
That's what a successful ablation requires and what the Isolator® Synergy™ EnCompass® clamp was built to deliver.
The EnCompass clamp utilizes Synergy technology to provide real-time, adaptive energy delivery – precisely to the specific tissue between the jaws.
The result: discrete, reproducible lesions that stand the test of time.
#SurgicalAblation#CardiacSurgery
AtriCure is growing our Regulatory Affairs and Scientific Affairs teams.
We’re hiring for Regulatory Affairs Specialist and Senior Principal Publications Specialist roles—opportunities for professionals with experience in regulatory submissions, clinical evidence, scientific publications, and medical writing.
Know someone who could be a great fit? We’d love to connect.
Explore open opportunities: https://okt.to/WjLnHe
Decades of evidence. Continuous innovation. One commitment to advancing LAA exclusion.
From development and testing to refinement and design, evidence has shaped the evolution of the AtriClip portfolio.
#AtriClip#LAAExclusion#CardiacSurgery
Hispanic Heritage Month is an opportunity to celebrate the stories, traditions, cultures, and contributions of Hispanic and Latino communities.
At AtriCure, we recognize the importance of diverse perspectives and the people who bring them to our workplace and communities every day.
This month, we celebrate heritage, connection, and the many contributions that make us stronger together.
#HispanicHeritageMonth
Recovery after an amputation is a journey—one that looks different for every person.
This #PainAwarenessMonth, we’re raising awareness of post-amputation pain and the impact it can have on daily life. With the right care and support, there are options to help manage pain along the way.
Learn more about post-amputation pain and available pain-management options: https://okt.to/eFwK67
#PainAwarenessMonth#Amputation#AmputationAwareness
How much do you really know about Afib?
There’s a lot of information out there—and not all of it is accurate. From symptoms and risk factors to treatment, it can be hard to separate Afib fact from fiction.
This #AFibAwarenessMonth, swipe through as we bust some common Afib myths and uncover the facts you should know. ❤️
Learn more: https://okt.to/RKHZ49
#AfibAwarenessMonth #Afib#AtrialFibrillation
What do two-year outcomes look like after concomitant epicardial surgical ablation during CABG?
A multicenter analysis of 537 patients from the TRAC-AF Registry found:
- 94% and 89% survival at 12 and 24 months, respectively.
- 85% and 77% freedom from atrial arrhythmias at
The EnCompass clamp utilizes Synergy technology to provide real-time, adaptive energy delivery – precisely to the specific tissue between the jaws.
The result: discrete, reproducible lesions that stand the test of time. Learn more:
Robust. Transmural. Contiguous.
That's what a successful ablation requires and what the Isolator® Synergy™ EnCompass® clamp was built to deliver.
#CardioTwitter#SurgicalAblation
BoxX-NoAF Clinical Trial
Duration: 00:55
A Message to Other Surgeons
Duration: 00:47
The Risks of Not Treating Afib
Duration: 00:30
Before and After Afib
Duration: 00:28
social media channels to keep updated on the latest at AtriCure.